The Phase III trial, which enrolled more than 10,000 children in Asia, showed that vaccination led to a 56 percent reduction in dengue cases.
Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea's SK Chemicals for the development of pneumococcal conjugate vaccine.
Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.
Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.
The results of the world’s first dengue vaccine efficacy study confirm the safety of Sanofi Pasteur’s dengue vaccine against 3 out of 4 dengue virus serotypes.
Sanofi Pasteur announced on Thursday promising efficacy results of its dengue vaccine candidate in an efficacy trial conducted in Thailand.
A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.
Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.